PAVmed (PAVM) Operating Income Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -31.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.15% |
| Jun 30, 2025 | 65.54% |
| Mar 31, 2025 | 61.20% |
| Dec 31, 2024 | 68.34% |
| Jun 30, 2024 | 16.99% |
| Mar 31, 2024 | 31.20% |
| Dec 31, 2023 | 33.41% |
| Sep 30, 2023 | 33.55% |
| Jun 30, 2023 | 29.81% |
| Mar 31, 2023 | -3.90% |
| Dec 31, 2022 | -25.01% |
| Sep 30, 2022 | -70.96% |
| Jun 30, 2022 | -81.06% |
| Mar 31, 2022 | -143.10% |
| Dec 31, 2021 | -160.44% |
| Sep 30, 2021 | -147.25% |
| Jun 30, 2021 | -158.68% |
| Mar 31, 2021 | -53.76% |
| Dec 31, 2020 | -64.69% |
| Sep 30, 2020 | -70.41% |
| Jun 30, 2020 | -51.07% |
| Mar 31, 2020 | -67.08% |
| Dec 31, 2019 | -38.53% |
| Sep 30, 2019 | -26.28% |
| Jun 30, 2019 | -21.19% |
| Mar 31, 2019 | -61.75% |
| Dec 31, 2018 | -75.38% |
| Sep 30, 2018 | -30.53% |
| Jun 30, 2018 | -35.49% |
| Mar 31, 2018 | 9.86% |
| Dec 31, 2017 | -10.40% |
| Sep 30, 2017 | -2.04% |
| Jun 30, 2017 | -53.75% |
| Mar 31, 2017 | -209.42% |